30.09.2022 • NewsArkemarenewable

Arkema Ups Expansion Plans for Pebax Elastomers

Arkema has boosted its previously announced expansion plans for Pebax elastomer at its Serquigny site in France. The company will now increase capacity by 40% rather than the 25% it announced in January this year.

The project will be undertaken in two separate phases. The first will raise output by 15% in the first quarter of 2023, then by a further 25% starting in the third quarter of next year.

In addition to the French expansion, Arkema said it is currently assessing further investment opportunities, including in Asia, in order to support the growth of its global customers in the sports, consumer electronics, medical and industrial markets. Applications range from running shoes and ski boots to catheters and to flexible device screens.

Arkema cited particularly strong growth for its bio-based Pebax grade called Rnew that is derived from renewable castor beans and can be fully recycled.

“We are very excited to announce this acceleration of our Pebax elastomer capacity increase. Demand continues to grow, especially for our bio-based Pebax Rnew range”, said Erwoan Pezron, senior vice president of Arkema’s high-performance polymers business. “There is no compromise between high performance and sustainability. Our customers demand both.”

Author: Elaine Burridge, Freelance Author

(c) Arkema
(c) Arkema

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.